On-site pathology services

Ended Definitive Contract Awarded Last action

Contract number
75F40120C00060
Awardee
Awarding agency
Obligated
$23,901,717

Award facts

Opportunity
  • FDASOL128123 Solicitation number
Contract value 97% obligated
$24,579,600.44 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Labor Hours
Place of performance
Jefferson, AR 72079, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00020 · The purpose of this modification is to DE-obligate funds, cancel non-funded items 4, 6, and 8, then close out the contract. -$218,910
Exercise an Option P00019 $836,042
Exercise an Option P00018 $0
Exercise an Option P00017 $190,954
Other Administrative Action P00016 · Key personnel changes- onsite pathology services $0
Exercise an Option P00015 · Exercise option year 4 -onsite pathology services $4,828,602
Supplemental Agreement for work within scope P00014 $0
Exercise an Option P00013 $4,684,717
Other Administrative Action P00012 · IPP MOD - onsite pathology services $0
Supplemental Agreement for work within scope P00011 $0
Exercise an Option P00010 $4,815,000
Funding Only Action P00009 $186,000
Supplemental Agreement for work within scope P00008 -$163,267
Funding Only Action P00007 $10,851
Exercise an Option P00006 $389,486
Funding Only Action P00005 $13,768
Exercise an Option P00004 $3,948,076
Funding Only Action P00003 $11,913
Funding Only Action P00002 $2,832
Other Administrative Action P00001 $583,000
Original award $3,782,653
Show all 21

About this award

Toxicologic Pathology Associates Inc. (UEI: PMMBWH3UHBV7) was awarded a definitive contract by the Food and Drug Administration (FDA) on July 14, 2020, to provide on-site pathology services. This labor-hours contract, designated as a Total Small Business set-aside, carries a ceiling value of $24.58 million and is slated for completion by September 15, 2025. The services will be performed at the FDA facility located in Jefferson, Arkansas. Pathology services of this nature typically support the FDA's regulatory mission by providing clinical and diagnostic pathology expertise necessary for product evaluation, safety assessments, and compliance activities.

The current contract status reflects a modification that de-obligates funds and cancels non-funded line items 4, 6, and 8 prior to contract closeout. This action suggests the scope of work has been refined or reduced from the original contract structure, with certain anticipated deliverables no longer required or funded. The use of a labor-hours pricing structure allows for flexible staffing arrangements to meet the FDA's evolving pathology service requirements throughout the performance period.

Quick answers

Who was awarded contract 75F40120C00060?

75F40120C00060 was awarded to Toxicologic Pathology Associates Inc. by Food and Drug Administration (Department of Health and Human Services) on July 14, 2020.

How much is contract 75F40120C00060 worth?

The government has obligated $23,901,717 on 75F40120C00060. Its current value, with exercised options, is $24,579,600.

Was contract 75F40120C00060 competed?

The extent of competition for 75F40120C00060 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award